Skip to main content
. Author manuscript; available in PMC: 2008 Apr 1.
Published in final edited form as: Mol Immunol. 2007 Feb 26;44(11):2884–2892. doi: 10.1016/j.molimm.2007.01.014

Fig. 5. CD4+CD25+ T cells are increased in SA-FasL treated long-term survivors.

Fig. 5

Fig. 5

Fig. 5

Spleens, mesenteric, pancreatic, and peripheral lymph nodes from individual recipients were harvested, processed, counted, and phenotyped by flow cytometric analysis to determine effective CD4+CD25+ T cell expansion and repopulation. Each cellular compartment was phenotyped using the surface markers specific for CD4+CD25+ T cells, CD3-FITC, CD25-PE, and CD4-APC and statistically analyzed by Mann-Whitney U test. (A) Absolute numbers of CD4+CD25+ T cells in individual recipients were calculated for each cellular compartment based on percent of CD3+CD4+CD25+ cells recovered. Absolute numbers of CD4+CD25+ cells calculated for each compartment were added to determine total cell recovery. Absolute numbers of (B) splenic and (C) pancreatic lymph node CD4+CD25+ T cells in individual recipients were calculated based on percent of CD3+ CD4+CD25+ cells recovered in spleen and pancreatic lymph nodes, respectively. * P<0.01. †P<0.05.